Development of Selective FXIa Inhibitors Based on Cyclic Peptides and Their Application for Safe Anticoagulation-Reference-Cited by-同舟云学术

Development of Selective FXIa Inhibitors Based on Cyclic Peptides and Their Application for Safe Anticoagulation

Published:2021-05-11 Issue:10 Volume:64 Page:6802-6813
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Carle Vanessa¹^ORCID,Wu Yuteng¹^ORCID,Mukherjee Rakesh¹,Kong Xu-Dong¹,Rogg Chloé¹,Laurent Quentin¹,Cecere Enza¹,Villequey Camille¹,Konakalla Madhuree S.¹,Maric Tamara¹^ORCID,Lamers Christina¹,Díaz-Perlas Cristina¹,Butler Kaycie¹^ORCID,Goto Junko²,Stegmayr Bernd²,Heinis Christian¹^ORCID

Affiliation:

1. Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland

2. Department of Public Health and Clinical Medicine, University of Umeå, SE-901 87 Umeå, Sweden

Funder

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

?cole Polytechnique F?d?rale de Lausanne

Innosuisse - Schweizerische Agentur f?r Innovationsf?rderung

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link